Pancreatic neuroendocrine neoplasms: survival trend analysis of a comprehensive center.

Sara CoelhoCláudia CostaAna Paula SantosPedro SouteiroJoana OliveiraJúlio OliveiraIsabel AzevedoIsabel TorresMaria José Bento

Published in: Endocrine oncology (Bristol, England) (2022)

The new therapeutic approaches did not induce better survival outcomes on Pan-NEN in recent years. This is possibly due to the indolent nature of NET grades 1 and 2, even metastatic, allowing patients to be submitted to new target therapies along their disease course.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
squamous cell carcinoma
chronic kidney disease
small cell lung cancer
peritoneal dialysis
prognostic factors
patient reported outcomes